These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20338108)

  • 41. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.
    Mjösberg JM; Trifari S; Crellin NK; Peters CP; van Drunen CM; Piet B; Fokkens WJ; Cupedo T; Spits H
    Nat Immunol; 2011 Sep; 12(11):1055-62. PubMed ID: 21909091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased expression of TIPE2 in alternatively activated macrophages is associated with eosinophilic inflammation and disease severity in chronic rhinosinusitis with nasal polyps.
    Yao Y; Wang ZC; Liu JX; Ma J; Chen CL; Deng YK; Liao B; Wang N; Wang H; Ning Q; Liu Z
    Int Forum Allergy Rhinol; 2017 Oct; 7(10):963-972. PubMed ID: 28665518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps.
    Kohanski MA; Workman AD; Patel NN; Hung LY; Shtraks JP; Chen B; Blasetti M; Doghramji L; Kennedy DW; Adappa ND; Palmer JN; Herbert DR; Cohen NA
    J Allergy Clin Immunol; 2018 Aug; 142(2):460-469.e7. PubMed ID: 29778504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation and expression of IL-32 in chronic rhinosinusitis.
    Soyka MB; Treis A; Eiwegger T; Menz G; Zhang S; Holzmann D; Akdis CA; Meyer N
    Allergy; 2012 Jun; 67(6):790-8. PubMed ID: 22486709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of NLRP3 Inflammasome in Eosinophilic and Non-eosinophilic Chronic Rhinosinusitis with Nasal Polyps.
    Lin H; Li Z; Lin D; Zheng C; Zhang W
    Inflammation; 2016 Dec; 39(6):2045-2052. PubMed ID: 27614764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of IL-13Rα2 in modulating IL-13-induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa.
    Liu J; Li YY; Andiappan AK; Yan Y; Tan KS; Ong HH; Thong KT; Ong YK; Yu FG; Low HB; Zhang YL; Shi L; Wang DY
    Allergy; 2018 Aug; 73(8):1673-1685. PubMed ID: 29405354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toll-like receptor 4-mediated expression of interleukin-32 via the c-Jun N-terminal kinase/protein kinase B/cyclic adenosine monophosphate response element binding protein pathway in chronic rhinosinusitis with nasal polyps.
    Cho JS; Kim JA; Park JH; Park IH; Han IH; Lee HM
    Int Forum Allergy Rhinol; 2016 Oct; 6(10):1020-1028. PubMed ID: 27173130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential short palate, lung, and nasal epithelial clone 1 suppression in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps: implications for pathogenesis and treatment.
    Wei Y; Han M; Wen W; Li H
    Curr Opin Allergy Clin Immunol; 2016 Feb; 16(1):31-8. PubMed ID: 26658012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased expression of type I (IFN-β) and type III (IFN-λ) interferons and interferon-stimulated genes in patients with chronic rhinosinusitis with and without nasal polyps.
    Hwang JW; Lee KJ; Choi IH; Han HM; Kim TH; Lee SH
    J Allergy Clin Immunol; 2019 Dec; 144(6):1551-1565.e2. PubMed ID: 31449915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SerpinB3/B4 Abates Epithelial Cell-Derived CXCL8/IL-8 Expression in Chronic Rhinosinusitis with Nasal Polyps.
    Bu X; Wang M; Yuan J; Song J; Luan G; Yu J; Wang Y; Li Y; Wang C; Zhang L
    J Immunol Res; 2024; 2024():8553447. PubMed ID: 38550710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proinflammatory impact of Staphylococcus aureus enterotoxin B on human nasal epithelial cells and inhibition by dexamethasone.
    Yu RL; Dong Z
    Am J Rhinol Allergy; 2009; 23(1):15-20. PubMed ID: 19379606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic rhinosinusitis with nasal polyps is associated with impaired TMEM16A-mediated epithelial chloride secretion.
    Salomon JJ; Albrecht T; Graeber SY; Scheuermann H; Butz S; Schatterny J; Mairbäurl H; Baumann I; Mall MA
    J Allergy Clin Immunol; 2021 Jun; 147(6):2191-2201.e2. PubMed ID: 33609628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The IL-37-Mex3B-Toll-like receptor 3 axis in epithelial cells in patients with eosinophilic chronic rhinosinusitis with nasal polyps.
    Liu JX; Liao B; Yu QH; Wang H; Liu YB; Guo CL; Wang ZC; Li ZY; Wang ZZ; Ruan JW; Pan L; Yao Y; Chen CL; Wang H; Liang Y; Zhen G; Liu Z
    J Allergy Clin Immunol; 2020 Jan; 145(1):160-172. PubMed ID: 31330219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. P-glycoprotein promotes epithelial T helper 2-associated cytokine secretion in chronic sinusitis with nasal polyps.
    Bleier BS; Nocera AL; Iqbal H; Hoang JD; Alvarez U; Feldman RE; Han X
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):488-94. PubMed ID: 24599606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps.
    Van Zele T; Holtappels G; Gevaert P; Bachert C
    Am J Rhinol Allergy; 2014; 28(3):192-8. PubMed ID: 24980230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-21 Is Increased in Nasal Polyposis and after Stimulation with Staphylococcus aureus Enterotoxin B.
    Calus L; Derycke L; Dullaers M; Van Zele T; De Ruyck N; Pérez-Novo C; Holtappels G; De Vos G; Lambrecht BN; Bachert C; Gevaert P
    Int Arch Allergy Immunol; 2017; 174(3-4):161-169. PubMed ID: 29131072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunomodulatory effect of cytosine-phosphate-guanosine (CpG)-oligonucleotides in nonasthmatic chronic rhinosinusitis: an explant model.
    Tan L; Rogers TJ; Hatzirodos N; Baker LM; Ooi E; Wormald PJ
    Am J Rhinol Allergy; 2009; 23(2):123-9. PubMed ID: 19401034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dupilumab prevents nasal epithelial function alteration by IL-4 in vitro: Evidence for its efficacy.
    Fieux M; Carsuzaa F; Bellanger Y; Bartier S; Fournier V; Lecron JC; Bainaud M; Louis B; Tringali S; Dufour X; Coste A; Favot L; Bequignon E
    Int Forum Allergy Rhinol; 2024 Aug; 14(8):1337-1349. PubMed ID: 38465788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.
    Pothoven KL; Norton JE; Hulse KE; Suh LA; Carter RG; Rocci E; Harris KE; Shintani-Smith S; Conley DB; Chandra RK; Liu MC; Kato A; Gonsalves N; Grammer LC; Peters AT; Kern RC; Bryce PJ; Tan BK; Schleimer RP
    J Allergy Clin Immunol; 2015 Sep; 136(3):737-746.e4. PubMed ID: 25840724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic Effects of Intranasal Tofacitinib on Chronic Rhinosinusitis with Nasal Polyps in Mice.
    Joo YH; Cho HJ; Jeon YJ; Kim JH; Jung MH; Jeon SY; Suh YS; Park JJ; Kim SW
    Laryngoscope; 2021 May; 131(5):E1400-E1407. PubMed ID: 32990335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.